Risk assessment and prediction of complications in pregnant women with heart disease

Anahita R. Chauhan, Neha Saxena


Background: There is a vast improvement in the survival and quality of life of patients with both major and minor structural and functional cardiac defects. Objective of present study was to calculate CARPREG (CARdiac disease in PREGnancy) risk score and test its efficacy in predicting the occurrence of adverse maternal cardiac events in patients with heart disease.

Methods: This was a prospective observational study where CARPREG score was calculated for 100 pregnant patients as soon as they were enrolled and the degree of risk and maternal complications were recorded and studied in relation to the score.

Results: Out of the 100 patients included in our study, it was found that Rheumatic heart disease (69%) with isolated mitral stenosis was the predominant cardiac problem. Maternal cardiac events complicated 14% pregnancies with congestive cardiac failure occurring most frequently. The complication rate was 1.56%, 5.56% and 66.67% in patients with CARPREG score of 0, 1 and ≥2 respectively. The sensitivity, specificity, positive predictive value and negative predictive value of CARPREG score in predicting the complications were 66.67%, 97.56%, 85.71% and 93.02% respectively. Hence, the score was efficacious in predicting the maternal cardiac complications and was found to be a statistically significant predictor of maternal complications (p value=7.39E-06).

Conclusions: The CARPREG risk index has a high specificity and negative predictive value with regards to cardiac complications in pregnant women with heart disease. It may, therefore, be routinely used to improve the assessment of cardiac risk before and during pregnancy.


CARPREG score, Cardiac complications, Rheumatic heart disease

Full Text:



Elkayam U, Gleicher N. Cardiac problems in pregnancy. Maternal aspects: the approach to the pregnant patient with heart disease. JAMA 1984;251:2838-9.

Weiss BM, von Segesser LK, Alon E, Seifert B, Turina MI. Outcome of cardiovascular surgery and pregnancy: a systematic review of the period 1984–1996. Am J Obstet Gynecol. 1998;179:1643-53.

Furenäs E, Eriksson P, Wennerholm UB, Dellborg M. Effect of maternal age and cardiac disease severity on outcome of pregnancy in women with congenital heart disease. Int Cardiol. 2017;243:197-203.

Siu SC, Sermer M, Colman JM, Alvarez AN, Mercier LA, Morton BC et al. Prospective multicentre study of pregnancy outcomes in women with heart disease. Circulation. 2001;104:515-521.

Chumpathong S, Sirithaweesit C, Pechpaisit N, Suraseranivongse S, von Bormann B, Titapant V et al. Predictors for complications in pregnant women with heart disease, a retrospective study. J Med Assoc Thai. 2014;97(7):730-5.

Jastrow N, Meyer P, Khairy P, Mercier LA, Dore A, Marcotte F. Prediction of complications in pregnant women with cardiac diseases referred to a tertiary center. Int J Cardiol. 2011;151(2):209-13.

Thorne S, MacGregor A, Nelson-Piercy C. Risks of contraception and pregnancyin heart disease. Heart. 2006;92:1520-5.

Regitz- Zagrosek V, Blomstrom Lundqvist C, Borghi C, Cifkova R, Ferreira R, Foidart JM, et al. ESC guidelines on the management of cardiovascular diseases during pregnancy of the European Society of Cardiology. Eur Heart J. 2011;32(24):3147-97.

Fu Q, Lin J. Predictive accuracy of three clinical risk assessment systems for cardiac complications among Chinese pregnant women with congenital heart disease. Int J Gynecol Obstet. 2016;134(2):140-4.

Pijuan-Domènech A, Galian L, Goya M, Casellas M, Merced C, Ferreira-Gonzalez I. Cardiac complications during pregnancy are better predicted with the modified WHO risk score. Int J Cardiol. 2015;195:149-54.

Balci A, Sollie-Szarynska KM, van der Bijl AG, Ruys TP, Mulder BJ, Roos-Hesselink JW. Prospective validation and assessment of cardiovascular and offspring risk models for pregnant women with congenital heart disease. Heart. 2014;100(17):1373-81.

Goya M, Casellas M, Merced C, Pijuan-Domenech A, Galián L, Dos L. Predictors of obstetric complications in women with heart disease. Matern Fetal Neonatal Med. 2016;29(14):2306-11.

Drenthen W, Pieper PG, Roos-Hesselink JW, van Lottum WA, Voors AA, Mulder BJ; ZAHARA Investigators. Outcome of pregnancy in women with congenital heart disease: a literature review. J Am Coll Card. 2007;49(24):2302-11.

Lu CW, Shih JC, Chen SY, Chiu HH, Wang JK, Chen CA. Comparison of 3 risk estimation methods for predicting cardiac outcomes in pregnant women with congenital heart disease. Circ J. 2015;79(7):1609-17.

Cauldwell M, Ghonim S, Uebing A, Swan L, Steer PJ, Gatzoulis M. Preconception counseling, predicting risk and outcomes in women with mWHO 3 and 4 heart disease. Int J Cardiol. 2017;234:76-80.

Lu CW, Wu MH, Wang JK, Lin MT, Chen CA, Chiu SN. Preconception counseling for women with congenital heart disease. Acta Cardiol Sin. 2015;31(6):500-6.